| | | | | |
RNAC Cartesian Therapeutics, Inc. Common Stock | $10,0350 | -1,91% | $317,37M | $144,58K | |
FUND Sprott Focus Trust, Inc. | $10,8850 | +1,54% | $317,19M | $31,30K | |
FATE Fate Therapeutics, Inc. | $2,3200 | -5,31% | $317,04M | $1,21M | |
NMRA Neumora Therapeutics, Inc. Common Stock | $1,6200 | +6,93% | $316,83M | $434,76K | |
GALT Galectin Therapeutics Inc. | $3,6950 | +3,50% | $316,66M | $153,23K | |
NREF NexPoint Real Estate Finance, Inc. | $17,4100 | +0,87% | $316,64M | $35,69K | |
POLE Andretti Acquisition Corp. II Class A Ordinary Shares | $10,8100 | -0,55% | $316,34M | $150,00 | |
PSBD Palmer Square Capital BDC Inc. | $10,2700 | +0,29% | $316,32M | $35,05K | |
| $3,2300 | +3,20% | $316,09M | $417,77K | |
| $6,4700 | +0,47% | $315,88M | $23,16K | |
SMTI Sanara MedTech Inc. Common Stock | $34,4400 | +0,58% | $315,59M | $369,21K | |
MLP Maui Land & Pineapple Co. | $15,6600 | +0,51% | $315,56M | $19,54K | |
AFB Alliance National Municipal Income Fund, Inc. | $10,9100 | -0,82% | $315,33M | $45,94K | |
| $41,0000 | -0,34% | $315,30M | $20,07K | |
TVA Texas Ventures Acquisition III Corp Class A Ordinary Share | $10,5400 | +0,00% | $315,30M | $5,62K | |
